首页 > 最新文献

OTO Open最新文献

英文 中文
The Locally Driven Temporal Bone Dissection Laboratory: A Sustainable Tool for Otologic Development in Sub-Saharan Africa. 当地驱动的颞骨解剖实验室:撒哈拉以南非洲耳科发展的可持续工具。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-23 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70134
Nina R Patel, Fayaz Jaffer, Aveline Kahinga, Shaban Mawala, Mary Jue Xu, Aslam Nkya, Jeffrey Sharon, Eric K Kim, Sayyeda Datoo-Jaffer, Stephanie Unterrieder, Ali F Jaffer

Objective: To evaluate the feasibility of a temporal bone dissection laboratory in Tanzania to support otologic surgical training for otolaryngologists in the region.

Study design: This prospective cohort study evaluates six temporal bone laboratory training sessions over the course of 11 months. Pretraining and posttraining surveys were distributed during the first year of implementation in 2023. Postsurveys were distributed both immediately and 6 months posttraining.

Setting: Single tertiary care academic medical center in Dar es Salaam, Tanzania.

Methods: Participant data for 47 attendees including country/region of practice, otologic procedures completed, and number of trainees/audiologists in their clinical practice were collected in the pretraining survey. A 5-point Likert scale was used to assess pretraining and posttraining comfort with completing common otologic procedures. Study outcomes included comfort level, barriers to implementing acquired knowledge, and overall training quality.

Results: The results highlight that participants did not have pretraining comfort with, exposure to, and training with many otologic surgeries. These limitations were largely attributed to barriers identified by participants including limited access to training, learning opportunities, and equipment for otologic procedures. Findings also indicate statistically significant increases in comfort level for the majority of common otologic procedures evaluated.

Conclusion: This study highlights that the training has been both feasible for and desired by participants, and has addressed critical needs in continued surgical training. Temporal bone dissection labs are a feasible and highly desired model to increase the otologic capacity of practicing otolaryngologists regionally and offer a promising approach for addressing the lack of training opportunities in the region.

目的:评价在坦桑尼亚建立颞骨解剖实验室以支持该地区耳鼻喉科医师耳外科培训的可行性。研究设计:这项前瞻性队列研究在11个月的时间里评估了6次颞骨实验室训练。在2023年实施的第一年分发了培训前和培训后调查。培训后调查立即分发,培训后6个月分发。环境:坦桑尼亚达累斯萨拉姆的单一三级保健学术医疗中心。方法:在训练前调查中收集47名学员的资料,包括执业国家/地区、已完成的耳科手术、临床执业学员/听力学家人数等。采用5点李克特量表评估训练前和训练后完成普通耳科手术的舒适度。研究结果包括舒适度、实施所学知识的障碍和整体培训质量。结果:结果强调,参与者在训练前对许多耳科手术没有舒适感,暴露和训练。这些限制很大程度上归因于参与者确定的障碍,包括获得培训、学习机会和耳科手术设备的机会有限。研究结果还表明,大多数普通耳科手术的舒适度在统计上有显著提高。结论:本研究强调了培训对参与者来说是可行的和期望的,并解决了继续手术培训的关键需求。颞骨解剖实验室是一种可行且备受期待的模式,可以提高区域执业耳鼻喉科医生的耳科能力,并为解决该地区缺乏培训机会提供了一种有希望的方法。
{"title":"The Locally Driven Temporal Bone Dissection Laboratory: A Sustainable Tool for Otologic Development in Sub-Saharan Africa.","authors":"Nina R Patel, Fayaz Jaffer, Aveline Kahinga, Shaban Mawala, Mary Jue Xu, Aslam Nkya, Jeffrey Sharon, Eric K Kim, Sayyeda Datoo-Jaffer, Stephanie Unterrieder, Ali F Jaffer","doi":"10.1002/oto2.70134","DOIUrl":"10.1002/oto2.70134","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the feasibility of a temporal bone dissection laboratory in Tanzania to support otologic surgical training for otolaryngologists in the region.</p><p><strong>Study design: </strong>This prospective cohort study evaluates six temporal bone laboratory training sessions over the course of 11 months. Pretraining and posttraining surveys were distributed during the first year of implementation in 2023. Postsurveys were distributed both immediately and 6 months posttraining.</p><p><strong>Setting: </strong>Single tertiary care academic medical center in Dar es Salaam, Tanzania.</p><p><strong>Methods: </strong>Participant data for 47 attendees including country/region of practice, otologic procedures completed, and number of trainees/audiologists in their clinical practice were collected in the pretraining survey. A 5-point Likert scale was used to assess pretraining and posttraining comfort with completing common otologic procedures. Study outcomes included comfort level, barriers to implementing acquired knowledge, and overall training quality.</p><p><strong>Results: </strong>The results highlight that participants did not have pretraining comfort with, exposure to, and training with many otologic surgeries. These limitations were largely attributed to barriers identified by participants including limited access to training, learning opportunities, and equipment for otologic procedures. Findings also indicate statistically significant increases in comfort level for the majority of common otologic procedures evaluated.</p><p><strong>Conclusion: </strong>This study highlights that the training has been both feasible for and desired by participants, and has addressed critical needs in continued surgical training. Temporal bone dissection labs are a feasible and highly desired model to increase the otologic capacity of practicing otolaryngologists regionally and offer a promising approach for addressing the lack of training opportunities in the region.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70134"},"PeriodicalIF":1.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors and Rates for Hypocalcemia After Pediatric Thyroidectomy: A Systematic Review and Meta-analysis. 儿童甲状腺切除术后低钙血症的危险因素和发生率:一项系统综述和荟萃分析。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-23 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70130
Marina Aweeda, Carly Fassler, Daniel R S Habib, Alexis B Miller, Carlos Ortega, Kavita Prasad, Chiu-Lan Chen, Sara H Duffus, Ryan H Belcher

Objective: Postoperative hypocalcemia after total thyroidectomy (TT) affects pediatric patients at higher rates than adult patients, yet its rate remains poorly defined. This study aims to determine the rates of transient, permanent, and any hypocalcemia after TT in pediatric patients and analyze potential risk factors.

Data sources: PubMed, EMBASE, Scopus, and Cochrane.

Review methods: A database search was conducted through March 2024 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data concerning postoperative hypocalcemia, risk factors, and clinical context were collected and analyzed. Transient hypocalcemia was defined as lasting less than 6 months and permanent as lasting greater than 6 months after surgery.

Results: In total, 67 studies with 7331 pediatric patients met the inclusion criteria. Surgical indications for TT in this cohort included malignant conditions (54.75%), benign conditions (19.70%), Graves' disease (18.59%), genetic syndromes (MEN2A/2B, RET mutation) (6.04%), and Hashimoto's thyroiditis (0.92%). The pooled incidence rates were 25.2% (95% CI 0.20-0.31) for transient, 7.4% (95% CI 0.05-0.10) for permanent, and 32.1% (95% CI 0.26-0.39) for any hypocalcemia. Fifteen of the included studies also examined risk factors for postoperative hypocalcemia. Patients undergoing TT for malignancy (odds ratio [OR] 2.82, 95% CI [1.18-6.73]; P = .02) or Graves' disease (OR 6.12, 95% CI [3.10-12.01]; P < .0001), as well as those undergoing any lymph node dissection (OR 3.71, 95% CI [1.95-7.06]; P < .0001) were at higher risk for postoperative hypocalcemia.

Conclusion: Hypocalcemia is a common postoperative complication of TT in pediatric patients. Risk factors include malignant surgical indication, Graves' disease, and any lymph node dissection.

目的:甲状腺全切除术(TT)后儿童患者低钙发生率高于成人患者,但其发生率仍不明确。本研究旨在确定儿科患者TT后短暂性、永久性和任何低钙血症的发生率,并分析潜在的危险因素。数据来源:PubMed, EMBASE, Scopus和Cochrane。评价方法:根据系统评价和荟萃分析(PRISMA)指南的首选报告项目,在2024年3月之前进行数据库搜索。收集和分析有关术后低钙、危险因素和临床背景的数据。短暂性低钙血症定义为术后持续时间小于6个月,永久性低钙血症定义为术后持续时间大于6个月。结果:共有67项研究7331例儿童患者符合纳入标准。该队列中TT的手术指征包括恶性(54.75%)、良性(19.70%)、Graves病(18.59%)、遗传综合征(MEN2A/2B、RET突变)(6.04%)和桥本甲状腺炎(0.92%)。短暂性的总发病率为25.2% (95% CI 0.20-0.31),永久性的为7.4% (95% CI 0.05-0.10),任何低钙血症的总发病率为32.1% (95% CI 0.26-0.39)。纳入的研究中有15项还检查了术后低钙血症的危险因素。因恶性肿瘤接受TT治疗的患者(优势比[OR] 2.82, 95% CI [1.18-6.73];P = .02)或Graves病(or 6.12, 95% CI [3.10-12.01];结论:低钙血症是小儿TT术后常见的并发症。危险因素包括恶性手术指征、Graves病和任何淋巴结清扫。
{"title":"Risk Factors and Rates for Hypocalcemia After Pediatric Thyroidectomy: A Systematic Review and Meta-analysis.","authors":"Marina Aweeda, Carly Fassler, Daniel R S Habib, Alexis B Miller, Carlos Ortega, Kavita Prasad, Chiu-Lan Chen, Sara H Duffus, Ryan H Belcher","doi":"10.1002/oto2.70130","DOIUrl":"10.1002/oto2.70130","url":null,"abstract":"<p><strong>Objective: </strong>Postoperative hypocalcemia after total thyroidectomy (TT) affects pediatric patients at higher rates than adult patients, yet its rate remains poorly defined. This study aims to determine the rates of transient, permanent, and any hypocalcemia after TT in pediatric patients and analyze potential risk factors.</p><p><strong>Data sources: </strong>PubMed, EMBASE, Scopus, and Cochrane.</p><p><strong>Review methods: </strong>A database search was conducted through March 2024 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Data concerning postoperative hypocalcemia, risk factors, and clinical context were collected and analyzed. Transient hypocalcemia was defined as lasting less than 6 months and permanent as lasting greater than 6 months after surgery.</p><p><strong>Results: </strong>In total, 67 studies with 7331 pediatric patients met the inclusion criteria. Surgical indications for TT in this cohort included malignant conditions (54.75%), benign conditions (19.70%), Graves' disease (18.59%), genetic syndromes (MEN2A/2B, RET mutation) (6.04%), and Hashimoto's thyroiditis (0.92%). The pooled incidence rates were 25.2% (95% CI 0.20-0.31) for transient, 7.4% (95% CI 0.05-0.10) for permanent, and 32.1% (95% CI 0.26-0.39) for any hypocalcemia. Fifteen of the included studies also examined risk factors for postoperative hypocalcemia. Patients undergoing TT for malignancy (odds ratio [OR] 2.82, 95% CI [1.18-6.73]; <i>P</i> = .02) or Graves' disease (OR 6.12, 95% CI [3.10-12.01]; <i>P</i> < .0001), as well as those undergoing any lymph node dissection (OR 3.71, 95% CI [1.95-7.06]; <i>P</i> < .0001) were at higher risk for postoperative hypocalcemia.</p><p><strong>Conclusion: </strong>Hypocalcemia is a common postoperative complication of TT in pediatric patients. Risk factors include malignant surgical indication, Graves' disease, and any lymph node dissection.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70130"},"PeriodicalIF":1.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costs of Sleep Endoscopy With Same-Day Versus Staged Surgery for Pediatric Obstructive Sleep Apnea. 儿童阻塞性睡眠呼吸暂停手术的睡眠内窥镜检查与当日手术相比的费用。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-23 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70133
Nicholas R Lenze, Michael M Allevato, William J Benjamin, Emmanuel Servin, Erin M Kirkham, David A Zopf, Joseph G Sinnwell

Objective: To compare the costs of staged versus same-day surgery after drug-induced sleep endoscopy (DISE) for pediatric obstructive sleep apnea (OSA).

Study design: Retrospective cohort study.

Setting: Single tertiary-care center in the United States from 2017 to 2023.

Methods: Patients were grouped into two surgical pathways: (1) DISE with same-day OSA surgery and (2) DISE with staged OSA surgery. Nonparametric tests and log-normal models were used to compare insurance payments, out-of-pocket costs, and hospital costs between pathways and to evaluate predictors of hospital costs.

Results: A total of 57 pediatric OSA patients with a mean (standard deviation [SD]) age of 10.8 (4.0) years were included. The mean insurance payments, out-of-pocket costs, and hospital costs were $12,158 (SD 10,412), $340 (SD 1168), and $11,965 (SD 9615), respectively. Patients who underwent DISE with staged OSA surgery had significantly higher hospital costs than those who underwent DISE with same-day OSA surgery (mean difference $8995, 95% CI 3528-14462; P < .001), and this effect persisted in an adjusted log-normal model (coefficient 0.82, 95% CI 0.34-1.30; P = .001). There were no significant differences in insurance payments or out-of-pocket costs by surgical pathway.

Conclusion: DISE with staged OSA surgery conferred higher hospital costs than DISE with same-day OSA surgery but did not increase financial burden on patients or payers. This finding has important implications for resource utilization for a common pediatric condition.

目的:比较儿童阻塞性睡眠呼吸暂停(OSA)药物诱导睡眠内镜(DISE)术后分期手术与当日手术的成本。研究设计:回顾性队列研究。环境:2017 - 2023年美国单一三级医疗中心。方法:将患者分为两种手术途径:(1)DISE +当日OSA手术;(2)DISE +分期OSA手术。非参数检验和对数正态模型用于比较不同途径之间的保险支付、自付费用和医院费用,并评估医院费用的预测因子。结果:共纳入57例儿童OSA患者,平均(标准差[SD])年龄为10.8(4.0)岁。平均保险支付、自付费用和住院费用分别为12,158美元(SD 10,412)、340美元(SD 1168)和11,965美元(SD 9615)。接受分阶段OSA手术的患者的住院费用明显高于接受同日OSA手术的患者(平均差值8995美元,95% CI 3528-14462;p = .001)。不同手术途径的保险支付和自付费用无显著差异。结论:分阶段OSA手术的DISE比同日OSA手术的DISE住院费用更高,但没有增加患者或支付方的经济负担。这一发现对儿科常见疾病的资源利用具有重要意义。
{"title":"Costs of Sleep Endoscopy With Same-Day Versus Staged Surgery for Pediatric Obstructive Sleep Apnea.","authors":"Nicholas R Lenze, Michael M Allevato, William J Benjamin, Emmanuel Servin, Erin M Kirkham, David A Zopf, Joseph G Sinnwell","doi":"10.1002/oto2.70133","DOIUrl":"10.1002/oto2.70133","url":null,"abstract":"<p><strong>Objective: </strong>To compare the costs of staged versus same-day surgery after drug-induced sleep endoscopy (DISE) for pediatric obstructive sleep apnea (OSA).</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Single tertiary-care center in the United States from 2017 to 2023.</p><p><strong>Methods: </strong>Patients were grouped into two surgical pathways: (1) DISE with same-day OSA surgery and (2) DISE with staged OSA surgery. Nonparametric tests and log-normal models were used to compare insurance payments, out-of-pocket costs, and hospital costs between pathways and to evaluate predictors of hospital costs.</p><p><strong>Results: </strong>A total of 57 pediatric OSA patients with a mean (standard deviation [SD]) age of 10.8 (4.0) years were included. The mean insurance payments, out-of-pocket costs, and hospital costs were $12,158 (SD 10,412), $340 (SD 1168), and $11,965 (SD 9615), respectively. Patients who underwent DISE with staged OSA surgery had significantly higher hospital costs than those who underwent DISE with same-day OSA surgery (mean difference $8995, 95% CI 3528-14462; <i>P</i> < .001), and this effect persisted in an adjusted log-normal model (coefficient 0.82, 95% CI 0.34-1.30; <i>P</i> = .001). There were no significant differences in insurance payments or out-of-pocket costs by surgical pathway.</p><p><strong>Conclusion: </strong>DISE with staged OSA surgery conferred higher hospital costs than DISE with same-day OSA surgery but did not increase financial burden on patients or payers. This finding has important implications for resource utilization for a common pediatric condition.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70133"},"PeriodicalIF":1.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis. 三氯乙酸局部治疗光化性唇炎。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-23 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70132
Victoria Kuta, S Mark Taylor

Importance: Actinic cheilitis is a condition of the lower lip with the potential for malignant transformation. Although many topical treatment options exist, most involve prolonged application periods with expected adverse effects that limit compliance.

Objective: Trichloroacetic acid is a widely used chemical peel that has been used for the treatment of precancerous skin lesions. This study aims to study the efficacy of 35% trichloroacetic acid as a topical treatment for actinic cheilitis.

Study design: Prospective cohort study of patients with actinic cheilitis presenting to our institution between September 2020 and December 2023. After treatment completion, patients were followed twice yearly for a minimum of 2 years.

Setting: Tertiary care center.

Methods: All patients with actinic cheilitis presenting to an otolaryngologist-head and neck surgeon at our institution within the study time frame were eligible. Exclusion criteria include patients <18 years of age, patients who were pregnant, and patients with a biopsy-proven malignancy of the lip. A topical 35% trichloroacetic acid peel was applied to the lower lip in the minor procedure clinic following bilateral mental nerve blocks. Patients were brought back 1 month later for follow-up ± a repeat treatment. Photos were taken prior to treatment and 1 month following their final treatment. The severity of actinic cheilitis was graded using a proposed grading scale for actinic cheilitis, and the burden of the condition was assessed using Skindex-16 Surveys. Visual analog scales were used to study adverse events. Patients were monitored for remission and recurrence.

Results: A total of 11 patients were enrolled, with the majority requiring one treatment to achieve clinical remission. All patients who completed their full treatment course entered clinical remission following their trichloroacetic acid treatment, and there have been no cases of recurrence to date. The most common reported side effects were redness and swelling. Patients reported a significant improvement in their quality of life following treatment.

Conclusion: This study suggests that a 35% trichloroacetic acid peel is a safe, well-tolerated, and effective treatment option for patients presenting with actinic cheilitis. Further follow-up is indicated to study the longevity of the achieved results.

Trial registration: This study is registered on Clinicaltrials.gov (NCT04744103). https://clinicaltrials.gov/study/NCT04744103?locStr=Halifax,%20NS,%20Canada&country=Canada&state=Nova%20Scotia&city=Halifax&cond=actinic%20cheilitis&rank=1.

重要性:光化性唇炎是一种具有潜在恶性转化的下唇疾病。虽然存在许多局部治疗方案,但大多数都涉及延长应用期和预期的不良反应,限制了依从性。目的:三氯乙酸是一种广泛使用的化学脱皮剂,已被用于治疗癌前皮肤病变。本研究旨在研究35%三氯乙酸局部治疗光化性唇炎的疗效。研究设计:前瞻性队列研究,纳入2020年9月至2023年12月期间来我院就诊的光化性口炎患者。治疗完成后,患者每年随访两次,至少随访2年。环境:三级保健中心。方法:所有在研究时间框架内就诊于我院耳鼻喉科-头颈外科医生的光化性舌炎患者均入选。排除标准包括患者结果:共纳入11例患者,大多数患者需要一次治疗才能达到临床缓解。所有完成整个疗程的患者在三氯乙酸治疗后均进入临床缓解期,迄今为止没有复发病例。最常见的副作用是红肿。患者报告治疗后生活质量显著改善。结论:本研究提示35%三氯乙酸去皮对于光化性唇炎患者是一种安全、耐受性良好且有效的治疗选择。建议进一步随访以研究取得的效果的寿命。试验注册:本研究已在Clinicaltrials.gov (NCT04744103)上注册。https://clinicaltrials.gov/study/NCT04744103?locStr=Halifax, % 20 ns, % 20 canada&country =加拿大=新星% 20 scotia&city = Halifax&cond =光化性% 20 cheilitis&rank = 1。
{"title":"Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis.","authors":"Victoria Kuta, S Mark Taylor","doi":"10.1002/oto2.70132","DOIUrl":"10.1002/oto2.70132","url":null,"abstract":"<p><strong>Importance: </strong>Actinic cheilitis is a condition of the lower lip with the potential for malignant transformation. Although many topical treatment options exist, most involve prolonged application periods with expected adverse effects that limit compliance.</p><p><strong>Objective: </strong>Trichloroacetic acid is a widely used chemical peel that has been used for the treatment of precancerous skin lesions. This study aims to study the efficacy of 35% trichloroacetic acid as a topical treatment for actinic cheilitis.</p><p><strong>Study design: </strong>Prospective cohort study of patients with actinic cheilitis presenting to our institution between September 2020 and December 2023. After treatment completion, patients were followed twice yearly for a minimum of 2 years.</p><p><strong>Setting: </strong>Tertiary care center.</p><p><strong>Methods: </strong>All patients with actinic cheilitis presenting to an otolaryngologist-head and neck surgeon at our institution within the study time frame were eligible. Exclusion criteria include patients <18 years of age, patients who were pregnant, and patients with a biopsy-proven malignancy of the lip. A topical 35% trichloroacetic acid peel was applied to the lower lip in the minor procedure clinic following bilateral mental nerve blocks. Patients were brought back 1 month later for follow-up ± a repeat treatment. Photos were taken prior to treatment and 1 month following their final treatment. The severity of actinic cheilitis was graded using a proposed grading scale for actinic cheilitis, and the burden of the condition was assessed using Skindex-16 Surveys. Visual analog scales were used to study adverse events. Patients were monitored for remission and recurrence.</p><p><strong>Results: </strong>A total of 11 patients were enrolled, with the majority requiring one treatment to achieve clinical remission. All patients who completed their full treatment course entered clinical remission following their trichloroacetic acid treatment, and there have been no cases of recurrence to date. The most common reported side effects were redness and swelling. Patients reported a significant improvement in their quality of life following treatment.</p><p><strong>Conclusion: </strong>This study suggests that a 35% trichloroacetic acid peel is a safe, well-tolerated, and effective treatment option for patients presenting with actinic cheilitis. Further follow-up is indicated to study the longevity of the achieved results.</p><p><strong>Trial registration: </strong>This study is registered on Clinicaltrials.gov (NCT04744103). https://clinicaltrials.gov/study/NCT04744103?locStr=Halifax,%20NS,%20Canada&country=Canada&state=Nova%20Scotia&city=Halifax&cond=actinic%20cheilitis&rank=1.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70132"},"PeriodicalIF":1.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Public Perception of Over-the-Counter Hearing Aids: A Sentiment and Thematic Analysis of Consumer Reviews. 了解公众对非处方助听器的看法:消费者评论的情感和主题分析。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-21 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70131
Joshua W Cho, Olivia Tandadjaja, Charlie Henriks, Malaika Jamal, Kaitlin Hori, Joel Feier, Ziphron Russel, Ethan Lawrence, Nicole Greene, Janet S Choi

Objective: To analyze public perceptions of over-the-counter (OTC) hearing aids through sentiment and thematic analysis of online consumer reviews and their changes over time.

Study design: Sentiment and thematic analysis.

Setting: Online reviews from third-party and product websites.

Methods: All English online consumer reviews posted between 2016 and 2024 for OTC hearing aids (83 models) were recorded (n = 21,727). Sentiment analysis was performed using Valence Aware Dictionary and Sentiment Reasoner (VADER), a rule-based sentiment analysis tool incorporating natural language processing. VADER provides scores for each review ranging from -1 (most negative), 0 (neutral), to 1 (most positive). Additional thematic analysis was performed for the top 100 most positive, neutral, and negative reviews (n = 300).

Results: Overall, mean (SD) VADER sentiment score of online reviews was generally positive at 0.587 (0.411). Multivariable regression analysis showed that higher VADER scores were associated with higher-priced and behind-the-ear (BTE) type hearing aids. Although there was a significant increase in a number of reviews after the Food and Drug Administration's new establishment of the OTC hearing aid category in 2022, the mean sentiment scores slightly decreased (β =-.10, [95%CI: -0.12 to -0.09]). Thematic analysis revealed that positive sentiments highlighted the affordability and time-saving benefits of OTC hearing aids as alternatives to prescription models. Negative sentiments centered on sound quality, challenges with customer service, and inadequate amplification for those with severe hearing loss.

Conclusion: Customers generally viewed OTC hearing aids positively, while mixed experiences were present. When used as indicated for adults with mild to moderate hearing loss, OTC hearing aids may offer a viable alternative to prescription devices, improving accessibility and affordability.

目的:通过对在线消费者评论的情感和主题分析,分析公众对非处方助听器的看法及其随时间的变化。研究设计:情感和主题分析。设置:第三方网站和产品网站的在线评论。方法:记录2016年至2024年间发布的所有OTC助听器(83种型号)的英文在线消费者评论(n = 21,727)。情感分析使用价感知字典和情感推理器(VADER)进行,VADER是一种基于规则的情感分析工具,结合了自然语言处理。维德为每条评论提供分数,范围从-1(最负面),0(中性)到1(最积极)。对前100个最积极、最中立和最消极的评论(n = 300)进行了额外的主题分析。结果:总体而言,在线评论的维德情绪平均分(SD)普遍为正,为0.587(0.411)。多变量回归分析显示,较高的VADER评分与价格较高的耳后(BTE)型助听器相关。尽管在美国食品和药物管理局于2022年新设立OTC助听器类别后,评论数量显著增加,但平均情绪得分略有下降(β =-)。10, [95%CI: -0.12 ~ -0.09])。专题分析显示,积极的情绪突出了OTC助听器作为处方模型替代品的可负担性和节省时间的好处。负面情绪主要集中在音质、客户服务方面的挑战,以及严重听力损失的人的扩音能力不足。结论:消费者对OTC助听器的评价总体是积极的,但体验好坏参半。当有轻度到中度听力损失的成年人使用时,OTC助听器可能提供处方设备的可行替代方案,提高可及性和可负担性。
{"title":"Understanding Public Perception of Over-the-Counter Hearing Aids: A Sentiment and Thematic Analysis of Consumer Reviews.","authors":"Joshua W Cho, Olivia Tandadjaja, Charlie Henriks, Malaika Jamal, Kaitlin Hori, Joel Feier, Ziphron Russel, Ethan Lawrence, Nicole Greene, Janet S Choi","doi":"10.1002/oto2.70131","DOIUrl":"10.1002/oto2.70131","url":null,"abstract":"<p><strong>Objective: </strong>To analyze public perceptions of over-the-counter (OTC) hearing aids through sentiment and thematic analysis of online consumer reviews and their changes over time.</p><p><strong>Study design: </strong>Sentiment and thematic analysis.</p><p><strong>Setting: </strong>Online reviews from third-party and product websites.</p><p><strong>Methods: </strong>All English online consumer reviews posted between 2016 and 2024 for OTC hearing aids (83 models) were recorded (n = 21,727). Sentiment analysis was performed using Valence Aware Dictionary and Sentiment Reasoner (VADER), a rule-based sentiment analysis tool incorporating natural language processing. VADER provides scores for each review ranging from -1 (most negative), 0 (neutral), to 1 (most positive). Additional thematic analysis was performed for the top 100 most positive, neutral, and negative reviews (n = 300).</p><p><strong>Results: </strong>Overall, mean (SD) VADER sentiment score of online reviews was generally positive at 0.587 (0.411). Multivariable regression analysis showed that higher VADER scores were associated with higher-priced and behind-the-ear (BTE) type hearing aids. Although there was a significant increase in a number of reviews after the Food and Drug Administration's new establishment of the OTC hearing aid category in 2022, the mean sentiment scores slightly decreased (<i>β</i> =-.10, [95%CI: -0.12 to -0.09]). Thematic analysis revealed that positive sentiments highlighted the affordability and time-saving benefits of OTC hearing aids as alternatives to prescription models. Negative sentiments centered on sound quality, challenges with customer service, and inadequate amplification for those with severe hearing loss.</p><p><strong>Conclusion: </strong>Customers generally viewed OTC hearing aids positively, while mixed experiences were present. When used as indicated for adults with mild to moderate hearing loss, OTC hearing aids may offer a viable alternative to prescription devices, improving accessibility and affordability.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70131"},"PeriodicalIF":1.8,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093246/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Bilateral Internal Jugular Parathyroid Hormone Measurements in Optimizing Hyperparathyroidism Surgery Outcomes. 双侧颈内甲状旁腺激素测量在优化甲状旁腺功能亢进手术结果中的有效性。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-16 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70122
Davi Knoll Ribeiro, Murilo Catafesta das Neves, Rodrigo Oliviera Santos, Monique Nakayama Ohe, Marise Lazaretti-Castro, Marcello Rosano, Marcio Abrahao

Objective: This study aimed to assess the effectiveness of intraoperative parathyroid hormone (PTH) measurements from bilateral internal jugular veins (BIJVs) in determining parathyroid gland laterality during surgery for primary hyperparathyroidism (PHPT).

Study design: Prospective cohort study.

Setting: Single tertiary care center, February 2021 to February 2023.

Methods: All patients underwent intraoperative BIJV PTH measurements during parathyroidectomy. Preoperative localization of abnormal parathyroid glands was performed using cervical ultrasound (USG) and sestamibi scans (MIBI). Receiver operating characteristic (ROC) analysis was performed to determine the best performance (sensitivity and specificity) for predicting parathyroid gland laterality.

Results: A total of 124 patients underwent surgery during the study. PTH measurements from BIJV successfully confirmed the laterality of parathyroid adenomas in 102 cases (82.3%, P = .001). Intraoperative BIJV PTH measurements proved to be the most effective method for determining parathyroid gland laterality, with an accuracy of 82.3%. ROC curve analysis identified an optimal cutoff point of 16.7% for the percentage difference between right and left BIJV PTH values. The area under the curve (AUC) was 0.882, indicating high diagnostic accuracy. This cutoff yielded a sensitivity of 76.5% and a specificity of 95.5%. Additionally, no patients experienced complications related to the internal jugular vein (IJV) procedure.

Conclusion: Intraoperative BIJV PTH measurement is a valuable adjunct in parathyroidectomy, improving localization and enhancing surgical outcomes in PHPT patients.

目的:本研究旨在评估术中双侧颈内静脉(BIJVs)测量甲状旁腺激素(PTH)在原发性甲状旁腺功能亢进(PHPT)手术中确定甲状旁腺侧边性的有效性。研究设计:前瞻性队列研究。环境:单一三级护理中心,2021年2月至2023年2月。方法:所有患者在甲状旁腺切除术中均行术中BIJV PTH测量。术前使用宫颈超声(USG)和sestamibi扫描(MIBI)对异常甲状旁腺进行定位。进行受试者工作特征(ROC)分析,以确定预测甲状旁腺偏侧的最佳性能(敏感性和特异性)。结果:共有124例患者在研究期间接受了手术。102例(82.3%,P = .001)患者通过BIJV的PTH检测成功确认了甲状旁腺瘤的侧侧性。术中BIJV PTH测量被证明是确定甲状旁腺侧边最有效的方法,准确率为82.3%。ROC曲线分析确定右侧和左侧BIJV PTH值百分比差异的最佳截断点为16.7%。曲线下面积(AUC)为0.882,诊断准确率高。该截止值的敏感性为76.5%,特异性为95.5%。此外,没有患者出现与颈内静脉(IJV)手术相关的并发症。结论:术中BIJV PTH测量是甲状旁腺切除术中有价值的辅助手段,可以改善PHPT患者的定位,提高手术效果。
{"title":"Effectiveness of Bilateral Internal Jugular Parathyroid Hormone Measurements in Optimizing Hyperparathyroidism Surgery Outcomes.","authors":"Davi Knoll Ribeiro, Murilo Catafesta das Neves, Rodrigo Oliviera Santos, Monique Nakayama Ohe, Marise Lazaretti-Castro, Marcello Rosano, Marcio Abrahao","doi":"10.1002/oto2.70122","DOIUrl":"10.1002/oto2.70122","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the effectiveness of intraoperative parathyroid hormone (PTH) measurements from bilateral internal jugular veins (BIJVs) in determining parathyroid gland laterality during surgery for primary hyperparathyroidism (PHPT).</p><p><strong>Study design: </strong>Prospective cohort study.</p><p><strong>Setting: </strong>Single tertiary care center, February 2021 to February 2023.</p><p><strong>Methods: </strong>All patients underwent intraoperative BIJV PTH measurements during parathyroidectomy. Preoperative localization of abnormal parathyroid glands was performed using cervical ultrasound (USG) and sestamibi scans (MIBI). Receiver operating characteristic (ROC) analysis was performed to determine the best performance (sensitivity and specificity) for predicting parathyroid gland laterality.</p><p><strong>Results: </strong>A total of 124 patients underwent surgery during the study. PTH measurements from BIJV successfully confirmed the laterality of parathyroid adenomas in 102 cases (82.3%, <i>P</i> = .001). Intraoperative BIJV PTH measurements proved to be the most effective method for determining parathyroid gland laterality, with an accuracy of 82.3%. ROC curve analysis identified an optimal cutoff point of 16.7% for the percentage difference between right and left BIJV PTH values. The area under the curve (AUC) was 0.882, indicating high diagnostic accuracy. This cutoff yielded a sensitivity of 76.5% and a specificity of 95.5%. Additionally, no patients experienced complications related to the internal jugular vein (IJV) procedure.</p><p><strong>Conclusion: </strong>Intraoperative BIJV PTH measurement is a valuable adjunct in parathyroidectomy, improving localization and enhancing surgical outcomes in PHPT patients.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70122"},"PeriodicalIF":1.8,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12082082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparities in Posthospitalization Disposition Following Tracheotomy: A National Analysis. 气管切开术后住院处置的差异:一项全国分析。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-16 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70129
Radhika Duggal, Sarah Benyo, Elizabeth N Dewey, Rebecca C Nelson, Paul C Bryson, Michael S Benninger, Brandon Hopkins, William S Tierney

Objective: Previous studies have demonstrated the impact of sociodemographic factors on disease development, management, and outcomes in adult and pediatric populations. Given that postoperative management is key in reducing complications following a tracheotomy, we assessed the impact of sociodemographic factors on a patient's discharge disposition.

Study design: Cross-sectional study.

Setting: Health Care Utilization Project's (HCUP) National Inpatient Survey (NIS).

Methods: The HCUP NIS was queried for all patients undergoing tracheotomy between 2017 and 2021. All analyses were performed using R Version 4.3.1 survey procedures to account for strata and cluster effects.

Results: We identified 81,069 admissions during which a tracheotomy was performed and, after appropriate weighting for the HCUP NIS survey design, found that 15.1% of admissions resulted in routine discharge, 4.5% transferred to a short-term hospital, 52.3% transferred to a skilled nursing facility (SNF)/intermediate care facility (ICF)/other facility, 16.9% discharged with home health care. Admissions routinely discharged had the lowest median (interquartile range) age (48 [23, 61] years), whereas admissions resulting in death or transfer to a SNF/ICF/other facility type had the greatest age (63 [53, 70] years). On both univariable and multivariable analyses, age, race, sex, insurance type, geographic region, and hospital size were associated with discharge disposition.

Conclusion: Our study highlights that disparities exist among patient populations and were found in both unadjusted and adjusted analyses. Further attention and resource allocation for the care of patients with a tracheostomy may work toward identifying sources of disparity, which may be modified to improve patient care.

目的:以前的研究已经证明了社会人口因素对成人和儿童人群的疾病发展、管理和结局的影响。鉴于术后管理是减少气管切开术并发症的关键,我们评估了社会人口因素对患者出院处置的影响。研究设计:横断面研究。背景:卫生保健利用项目(HCUP)全国住院患者调查(NIS)。方法:对2017 - 2021年所有气管切开术患者的HCUP NIS进行查询。所有分析均使用R Version 4.3.1调查程序进行,以考虑地层和集群效应。结果:我们确定了81,069例接受气管切开术的入院患者,在对HCUP NIS调查设计进行适当加权后,发现15.1%的入院患者常规出院,4.5%转到短期医院,52.3%转到熟练护理机构(SNF)/中级护理机构(ICF)/其他机构,16.9%的患者出院时接受了家庭保健。常规出院的入院患者年龄中位数最低(四分位数范围)(48岁[23,61]),而入院导致死亡或转移到SNF/ICF/其他设施类型的患者年龄最大(63岁[53,70])。在单变量和多变量分析中,年龄、种族、性别、保险类型、地理区域和医院规模与出院处置有关。结论:我们的研究强调在患者群体中存在差异,并且在未调整和调整的分析中都发现了差异。对气管切开术患者护理的进一步关注和资源分配可能有助于确定差异的来源,从而改进患者护理。
{"title":"Disparities in Posthospitalization Disposition Following Tracheotomy: A National Analysis.","authors":"Radhika Duggal, Sarah Benyo, Elizabeth N Dewey, Rebecca C Nelson, Paul C Bryson, Michael S Benninger, Brandon Hopkins, William S Tierney","doi":"10.1002/oto2.70129","DOIUrl":"10.1002/oto2.70129","url":null,"abstract":"<p><strong>Objective: </strong>Previous studies have demonstrated the impact of sociodemographic factors on disease development, management, and outcomes in adult and pediatric populations. Given that postoperative management is key in reducing complications following a tracheotomy, we assessed the impact of sociodemographic factors on a patient's discharge disposition.</p><p><strong>Study design: </strong>Cross-sectional study.</p><p><strong>Setting: </strong>Health Care Utilization Project's (HCUP) National Inpatient Survey (NIS).</p><p><strong>Methods: </strong>The HCUP NIS was queried for all patients undergoing tracheotomy between 2017 and 2021. All analyses were performed using R Version 4.3.1 survey procedures to account for strata and cluster effects.</p><p><strong>Results: </strong>We identified 81,069 admissions during which a tracheotomy was performed and, after appropriate weighting for the HCUP NIS survey design, found that 15.1% of admissions resulted in routine discharge, 4.5% transferred to a short-term hospital, 52.3% transferred to a skilled nursing facility (SNF)/intermediate care facility (ICF)/other facility, 16.9% discharged with home health care. Admissions routinely discharged had the lowest median (interquartile range) age (48 [23, 61] years), whereas admissions resulting in death or transfer to a SNF/ICF/other facility type had the greatest age (63 [53, 70] years). On both univariable and multivariable analyses, age, race, sex, insurance type, geographic region, and hospital size were associated with discharge disposition.</p><p><strong>Conclusion: </strong>Our study highlights that disparities exist among patient populations and were found in both unadjusted and adjusted analyses. Further attention and resource allocation for the care of patients with a tracheostomy may work toward identifying sources of disparity, which may be modified to improve patient care.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70129"},"PeriodicalIF":1.8,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12082083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144094248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Face and Neck Pilomatricoma Excision Using an Endoscope-Assisted Hairline Approach. 应用内窥镜辅助发际入路切除面部及颈部毛瘤。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-15 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70104
Ken Woo, Dong Kun Lee, Seung Hoon Woo

Objective: Traditional transcutaneous approaches for pilomatricoma excision in the face and neck are effective but often leave conspicuous scars that compromise cosmetic outcomes. We aimed to evaluate a refined endoscope-assisted hairline approach that uses a concealed scalp incision and enhanced endoscopic visualization to improve esthetic results while maintaining surgical efficacy.

Study design: Prospective observational study.

Setting: Dankook University School of Medicine, Korea.

Methods: Fifty patients with benign pilomatricomas of the face and neck were prospectively enrolled and allocated into two groups. Group A (n = 25) underwent the refined endoscope-assisted hairline approach, whereas Group B (n = 25) received the conventional transcutaneous approach. Clinical data including operative time and postoperative complications were recorded. Cosmetic outcomes were objectively evaluated using standardized photographic documentation and patient satisfaction scores collected at 3 and 12 months postoperatively.

Results: The mean operative time was significantly longer in Group A compared to Group B (P < .001), reflecting the technical intricacies of the hairline approach. No significant differences were observed between the two groups in hospital stay or overall complication rates. Importantly, cosmetic satisfaction scores were significantly higher in Group A (P < .001), with objective assessments consistently demonstrating reduced scar visibility and superior preservation of skin integrity.

Conclusion: The refined endoscope-assisted hairline approach is a safe and highly effective technique for pilomatricoma excision in cosmetically sensitive facial and neck regions. This innovative method offers significant improvements in esthetic outcomes without compromising safety, representing a distinct advance over conventional methods.

目的:传统的经皮方法切除面部和颈部毛瘤是有效的,但往往留下明显的疤痕,损害美容效果。我们的目的是评估一种改进的内窥镜辅助发际入路,该入路使用隐藏的头皮切口和增强的内窥镜可视化来改善美学效果,同时保持手术疗效。研究设计:前瞻性观察性研究。单位:韩国檀国大学医学院。方法:将50例面部和颈部良性毛瘤患者前瞻性地分为两组。A组(n = 25)采用改良内窥镜辅助发际入路,B组(n = 25)采用常规经皮入路。记录手术时间、术后并发症等临床资料。在术后3个月和12个月,使用标准化的照片记录和患者满意度评分客观评估美容结果。结果:A组的平均手术时间明显长于B组(P P)。结论:精致内窥镜辅助发际入路是一种安全、高效的面部及颈部美容敏感部位毛瘤切除技术。这种创新的方法在不影响安全性的情况下显著改善了美观效果,代表了传统方法的明显进步。
{"title":"Face and Neck Pilomatricoma Excision Using an Endoscope-Assisted Hairline Approach.","authors":"Ken Woo, Dong Kun Lee, Seung Hoon Woo","doi":"10.1002/oto2.70104","DOIUrl":"https://doi.org/10.1002/oto2.70104","url":null,"abstract":"<p><strong>Objective: </strong>Traditional transcutaneous approaches for pilomatricoma excision in the face and neck are effective but often leave conspicuous scars that compromise cosmetic outcomes. We aimed to evaluate a refined endoscope-assisted hairline approach that uses a concealed scalp incision and enhanced endoscopic visualization to improve esthetic results while maintaining surgical efficacy.</p><p><strong>Study design: </strong>Prospective observational study.</p><p><strong>Setting: </strong>Dankook University School of Medicine, Korea.</p><p><strong>Methods: </strong>Fifty patients with benign pilomatricomas of the face and neck were prospectively enrolled and allocated into two groups. Group A (n = 25) underwent the refined endoscope-assisted hairline approach, whereas Group B (n = 25) received the conventional transcutaneous approach. Clinical data including operative time and postoperative complications were recorded. Cosmetic outcomes were objectively evaluated using standardized photographic documentation and patient satisfaction scores collected at 3 and 12 months postoperatively.</p><p><strong>Results: </strong>The mean operative time was significantly longer in Group A compared to Group B (<i>P</i> < .001), reflecting the technical intricacies of the hairline approach. No significant differences were observed between the two groups in hospital stay or overall complication rates. Importantly, cosmetic satisfaction scores were significantly higher in Group A (<i>P</i> < .001), with objective assessments consistently demonstrating reduced scar visibility and superior preservation of skin integrity.</p><p><strong>Conclusion: </strong>The refined endoscope-assisted hairline approach is a safe and highly effective technique for pilomatricoma excision in cosmetically sensitive facial and neck regions. This innovative method offers significant improvements in esthetic outcomes without compromising safety, representing a distinct advance over conventional methods.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70104"},"PeriodicalIF":1.8,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12080212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Office-Based Blue Laser Versus Coblation Therapy for Inferior Turbinate Hypertrophy: A Pilot Study. 基于办公室的蓝色激光与消融治疗下鼻甲肥大:一项试点研究。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-14 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70127
Abdul-Latif Hamdan, Zeina Maria Semaan, Lana Ghzayel, Yara Yammine, Jonathan Abou Chaar, Jad Hosri, Patrick Abou Raji Feghali, Anne Marie Daou, Elie Alam

Objective: The aim of this pilot study is to compare the effectiveness of office-based blue laser therapy with coblation therapy in patients with inferior turbinate hypertrophy (ITH).

Study design: Retrospective chart review.

Setting: Tertiary referral center.

Methods: Patients presenting with nasal obstruction between November 2022 and November 2024, and underwent coblation or blue laser therapy for turbinate reduction were reviewed. Demographic data included age, gender, smoking, history of allergy, history of reflux disease, and history of prior nasal surgery. All patients had filled the nasal obstruction symptom evaluation (NOSE) questionnaire and the visual analog scale (VAS) before and on follow-up after treatment. Patient's level of comfort during the procedure was also rated using a 10-point Likert scale with a higher score indicating a greater level of comfort.

Results: A total of 10 patients underwent office-based blue laser therapy for turbinate reduction, and 10 patients underwent office-based coblation of the inferior turbinates. In the subgroup of patients who underwent office-based blue laser therapy, the mean NOSE score and VAS score decreased significantly (P = .005). In the subgroup of patients who underwent coblation, the mean NOSE score and VAS score decreased significantly (P = .005). When comparing the two subgroups, the difference in the drop of the NOSE score was not statistically significant (P = .198). Similarly, the difference in the drop of VAS score was not statistically significant (P = .280).

Conclusion: The results of this investigation indicate that both coblation therapy and blue laser therapy are effective office-based treatment modalities in patients with ITH with comparable results.

目的:本初步研究的目的是比较基于办公室的蓝色激光治疗与消融治疗下鼻甲肥大(ITH)患者的有效性。研究设计:回顾性图表回顾。单位:三级转诊中心。方法:回顾性分析2022年11月至2024年11月期间出现鼻塞并接受消融或蓝色激光治疗鼻甲复位的患者。人口统计数据包括年龄、性别、吸烟、过敏史、反流病史和既往鼻手术史。所有患者均在治疗前和治疗后随访时填写鼻塞症状评价问卷(NOSE)和视觉模拟量表(VAS)。患者在手术过程中的舒适度也使用10分李克特量表进行评分,得分越高表明舒适度越高。结果:共有10例患者接受了基于办公室的蓝色激光治疗鼻甲复位,10例患者接受了基于办公室的下鼻甲消融。在接受办公室蓝色激光治疗的患者亚组中,平均鼻翼评分和VAS评分显著下降(P = 0.005)。在接受消融治疗的患者亚组中,平均鼻翼评分和VAS评分显著下降(P = 0.005)。两亚组比较,鼻翼评分下降差异无统计学意义(P = 0.198)。同样,两组VAS评分下降差异无统计学意义(P = 0.280)。结论:本研究结果表明,消融治疗和蓝色激光治疗是治疗ITH患者有效的办公室治疗方式,结果相当。
{"title":"Office-Based Blue Laser Versus Coblation Therapy for Inferior Turbinate Hypertrophy: A Pilot Study.","authors":"Abdul-Latif Hamdan, Zeina Maria Semaan, Lana Ghzayel, Yara Yammine, Jonathan Abou Chaar, Jad Hosri, Patrick Abou Raji Feghali, Anne Marie Daou, Elie Alam","doi":"10.1002/oto2.70127","DOIUrl":"https://doi.org/10.1002/oto2.70127","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this pilot study is to compare the effectiveness of office-based blue laser therapy with coblation therapy in patients with inferior turbinate hypertrophy (ITH).</p><p><strong>Study design: </strong>Retrospective chart review.</p><p><strong>Setting: </strong>Tertiary referral center.</p><p><strong>Methods: </strong>Patients presenting with nasal obstruction between November 2022 and November 2024, and underwent coblation or blue laser therapy for turbinate reduction were reviewed. Demographic data included age, gender, smoking, history of allergy, history of reflux disease, and history of prior nasal surgery. All patients had filled the nasal obstruction symptom evaluation (NOSE) questionnaire and the visual analog scale (VAS) before and on follow-up after treatment. Patient's level of comfort during the procedure was also rated using a 10-point Likert scale with a higher score indicating a greater level of comfort.</p><p><strong>Results: </strong>A total of 10 patients underwent office-based blue laser therapy for turbinate reduction, and 10 patients underwent office-based coblation of the inferior turbinates. In the subgroup of patients who underwent office-based blue laser therapy, the mean NOSE score and VAS score decreased significantly (<i>P</i> = .005). In the subgroup of patients who underwent coblation, the mean NOSE score and VAS score decreased significantly (<i>P</i> = .005). When comparing the two subgroups, the difference in the drop of the NOSE score was not statistically significant (<i>P</i> = .198). Similarly, the difference in the drop of VAS score was not statistically significant (<i>P</i> = .280).</p><p><strong>Conclusion: </strong>The results of this investigation indicate that both coblation therapy and blue laser therapy are effective office-based treatment modalities in patients with ITH with comparable results.</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70127"},"PeriodicalIF":1.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12076342/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of a Novel Autoinflation Device to Treat Pediatric Otitis Media With Effusion At-Home. 一种新型自动充气装置治疗儿童中耳炎积液的可行性。
IF 1.8 Q2 OTORHINOLARYNGOLOGY Pub Date : 2025-05-14 eCollection Date: 2025-04-01 DOI: 10.1002/oto2.70128
Maria-Jose Soto, Nanki Hura, Intan Oldakowska, Matthew Oldakowski, Paul Bumbak, Peter Luke Santa Maria

Objective: Otitis media with effusion (OME) affects 90% of children before school age, with current guidelines recommending tympanostomy tubes for persistent OME and hearing loss after 3 months of "Watchful Waiting," due to the risk of complications including long-term conductive hearing loss. Current nonsurgical treatment options are limited. This study evaluates the feasibility of at-home use of a novel prototype autoinflation device for children with OME or eustachian tube dysfunction.

Study design: Single-arm cohort study.

Setting: Pediatric otolaryngology private clinic.

Methods: Children aged 1 to 12 years with OME were recruited from a pediatric otolaryngology clinic and asked to use the device twice daily for 4 weeks. Baseline audiometry and tympanometry were performed at recruitment, with subsequent tympanometry testing after first use and at 2, 4, 8, and 12 weeks. Audiometry testing was repeated at week 4. Compliance was tracked using an App.

Results: Twenty-one patients were included (average age: 5.1 years, range: 2-12 years). After a single session, 86% of patients had middle ear pressure improvement in at least one ear, which maintained stable at 83% at week 4. Additionally, 86% of patients with hearing loss exhibited improvement at 4 weeks, where the average pure tone average in ears with baseline hearing loss improved from 26.8 to 18.9 dB HL.

Conclusion: These results demonstrate significant improvement in both tympanometry and audiometry after 4 weeks of device use. This indicates a strong potential benefit in regular ventilation of the middle ear for pediatric patients with OME undergoing "Watchful Waiting."

目的:中耳炎积液(OME)影响90%的学龄前儿童,目前的指南建议在“观察等待”3个月后持续性中耳炎和听力损失的鼓膜造瘘管,因为存在并发症的风险,包括长期传导性听力损失。目前的非手术治疗选择有限。本研究评估了在家中使用一种新型原型自动充气装置治疗OME或咽鼓管功能障碍儿童的可行性。研究设计:单臂队列研究。单位:小儿耳鼻喉科私人诊所。方法:从儿童耳鼻喉科门诊招募1至12岁的OME患儿,要求每天使用该装置两次,持续4周。在招募时进行基线听力测量和鼓室测量,在首次使用后和第2、4、8和12周进行鼓室测量。第4周再次进行听力测试。结果:纳入21例患者(平均年龄5.1岁,范围2-12岁)。单次治疗后,86%的患者至少有一只耳朵的中耳压得到改善,在第4周时稳定在83%。此外,86%的听力损失患者在4周时表现出改善,基线听力损失的耳朵平均纯音从26.8 dB HL改善到18.9 dB HL。结论:这些结果表明,在使用设备4周后,鼓室测量和听力测量均有显著改善。这表明常规中耳通气对处于“观察等待”期的OME患儿具有很强的潜在益处。
{"title":"Feasibility of a Novel Autoinflation Device to Treat Pediatric Otitis Media With Effusion At-Home.","authors":"Maria-Jose Soto, Nanki Hura, Intan Oldakowska, Matthew Oldakowski, Paul Bumbak, Peter Luke Santa Maria","doi":"10.1002/oto2.70128","DOIUrl":"https://doi.org/10.1002/oto2.70128","url":null,"abstract":"<p><strong>Objective: </strong>Otitis media with effusion (OME) affects 90% of children before school age, with current guidelines recommending tympanostomy tubes for persistent OME and hearing loss after 3 months of \"Watchful Waiting,\" due to the risk of complications including long-term conductive hearing loss. Current nonsurgical treatment options are limited. This study evaluates the feasibility of at-home use of a novel prototype autoinflation device for children with OME or eustachian tube dysfunction.</p><p><strong>Study design: </strong>Single-arm cohort study.</p><p><strong>Setting: </strong>Pediatric otolaryngology private clinic.</p><p><strong>Methods: </strong>Children aged 1 to 12 years with OME were recruited from a pediatric otolaryngology clinic and asked to use the device twice daily for 4 weeks. Baseline audiometry and tympanometry were performed at recruitment, with subsequent tympanometry testing after first use and at 2, 4, 8, and 12 weeks. Audiometry testing was repeated at week 4. Compliance was tracked using an App.</p><p><strong>Results: </strong>Twenty-one patients were included (average age: 5.1 years, range: 2-12 years). After a single session, 86% of patients had middle ear pressure improvement in at least one ear, which maintained stable at 83% at week 4. Additionally, 86% of patients with hearing loss exhibited improvement at 4 weeks, where the average pure tone average in ears with baseline hearing loss improved from 26.8 to 18.9 dB HL.</p><p><strong>Conclusion: </strong>These results demonstrate significant improvement in both tympanometry and audiometry after 4 weeks of device use. This indicates a strong potential benefit in regular ventilation of the middle ear for pediatric patients with OME undergoing \"Watchful Waiting.\"</p>","PeriodicalId":19697,"journal":{"name":"OTO Open","volume":"9 2","pages":"e70128"},"PeriodicalIF":1.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12076345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
OTO Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1